World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
12442
World Ranking
4125
National Ranking
1881

Phil Lieberman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Phil Lieberman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 146 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Phil Lieberman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Phil Lieberman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Phil Lieberman is affiliated with the University of Tennessee at Knoxville in the United States. Their research primarily focuses on the field of Medicine, with significant contributions to Immunology and Allergy, Surgery, Physiology, Pulmonary and Respiratory Medicine, and Immunology as subfields of study.

The scientist's work covers a range of topics including:

  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Eosinophilic Esophagitis
  • Asthma and respiratory diseases
  • Respiratory and Cough-Related Research
  • Drug-Induced Adverse Reactions
  • Immunodeficiency and Autoimmune Disorders

Phil Lieberman has published research in several frequent venues, with a strong presence in allergy and immunology journals. These include:

  • Annals of Allergy Asthma & Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Journal of Allergy and Clinical Immunology
  • Allergy
  • Journal of Clinical Immunology

Some notable recent papers authored in collaboration with others include:

  • Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis (2020), published in Journal of Allergy and Clinical Immunology
  • Drug allergy: A 2022 practice parameter update (2022), published in Journal of Allergy and Clinical Immunology
  • Rhinitis 2020: A practice parameter update (2020), published in Journal of Allergy and Clinical Immunology
  • COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic (2020), published in The Journal of Allergy and Clinical Immunology In Practice
  • AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis (2020), published in Gastroenterology

Frequent collaborators in their work have included Matthew Greenhawt, Marcus Shaker, David B.K. Golden, Julie Wang, and David R. Stukus. These partnerships reflect recurring co-authorship over multiple publications.

Best Publications

  • Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

    Joshua A. Boyce;Amal Assa'ad;A. Wesley Burks;Stacie M. Jones

  • Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

    Peter Valent;Cem Akin;Michel Arock;Knut Brockow

  • Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis

    Unknown

  • Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

    Jean Bousquet;Holger J. Schünemann;Akdis Togias;Claus Bachert

  • International consensus on (ICON) anaphylaxis

    F. Estelle R. Simons;Ledit R.F. Ardusso;M Beatrice Bilò;Victoria Cardona

  • Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group.

    Phil Lieberman;Carlos A. Camargo;Kari Bohlke;Hershel Jick

  • Anaphylaxis: a review of 601 cases.

    Luke M. Webb;Phil Lieberman

  • Anaphylaxis: A Review of 266 Cases

    Stephen F. Kemp;Richard F. Lockey;Bruce L. Wolf;Phil Lieberman

  • A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

    Warner Carr;Jonathan Bernstein;Phil Lieberman;Eli Meltzer

  • Biphasic anaphylactic reactions.

    Phil Lieberman

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    J Bousquet;P W Hellings;I Agache;A Bedbrook

  • Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations.

    John W. Tole;Phil Lieberman

  • Anaphylactic reactions during surgical and medical procedures.

    Phil Lieberman

  • Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis

    Charles H. Banov;Phil Lieberman

  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    Jean Bousquet;Jean Bousquet;Peter W. Hellings;Ioana Agache;Flore Amat

  • Epidemiology of anaphylaxis

    Phil Lieberman

  • Is diet partly responsible for differences in COVID-19 death rates between and within countries?

    Jean Bousquet;Josep M Anto;Guido Iaccarino;Wienczyslawa Czarlewski

  • The basics of histamine biology

    Phil Lieberman

  • Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

    J. Bousquet;A. Bedbrook;W. Czarlewski;G. L. Onorato

  • Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report.

    Joshua A. Boyce;Amal Assa'a;A. Wesley Burks;Stacie M. Jones

  • Regional Differences in EpiPen Prescriptions in the United States

    C.A. Camargo;S. Clark;M.S. Kaplan;P. Lieberman

Frequent Co-Authors

David Price
David Price University of Aberdeen
Claus Bachert
Claus Bachert Karolinska Institute
Jean Bousquet
Jean Bousquet University of Montpellier
F. Estelle R. Simons
F. Estelle R. Simons University of Manitoba
Eli O. Meltzer
Eli O. Meltzer University of California, Berkeley
Glenn T. Furuta
Glenn T. Furuta University of Colorado Denver
Lawrence F. Eichenfield
Lawrence F. Eichenfield University of California, San Diego
Michael A. Kaliner
Michael A. Kaliner National Institutes of Health
Richard F. Lockey
Richard F. Lockey University of South Florida
Pascal Demoly
Pascal Demoly University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can broaden career opportunities in healthcare and research. Nursing pathways, particularly those focusing on advanced practice, offer strong prospects. For example, choosing the easiest fnp program can be a great way to enter the field quickly while gaining essential clinical skills.

Another promising route is specialization in mental health. The top psychiatric mental health nurse practitioner programs online combine flexibility with high-quality clinical placements, critical for hands-on experience. If budget is a concern, researching cheap psych np programs ensures accessible education without compromising standards.

Understanding potential earnings is also important. Graduates pursuing clinical roles will benefit from insights into how much do dnp nurses make, helping to guide career decisions based on financial goals and geographic preferences.

By combining Immunology knowledge with these specialized nursing degrees, professionals can unlock diverse career pathways, from clinical practice to research and leadership roles.

Best Scientists Citing Phil Lieberman

Trending Scientists

Recently Published Articles